Ambroxol (group of benzilamides) belongs to secretolitical and secretomotoric medicinal products. It possesses expressed expectorant effect. Mechanism of action of the medicinal product is stipulated by stimulation of serous cells of tonsils of bronchial tubes’ mucous membrane, increasing of mucous secretion content and changing of correlation of serous and mucous components of phlegm, breached under pathological processes in lungs.


Lambrotin 15: each 5 ml contains:

Ambroxol Hydrochloride BP 15 mg;

Cetirizine Hydrochloride BP 2,5 mg.

Lambrotin 30: each 5 ml contains:

Ambroxol Hydrochloride BP 30 mg;

Cetirizine Hydrochloride BP 5 mg.

Lambrotin should be used with the following indications:

  • Respiratory tract diseases with discharge of viscous mucus;
  • bronchial asthma with difficulty sputum discharge;
  • acute and chronic bronchitis;
  • pneumonia;
  • bronchoectatic disease;
  • chronic obstructive pulmonary disease.

For oral use only.

For children, it is recommended to take Lambrotin 15 (ambroxol 15 mg /5 ml) in following doses:

Children up to 2 years: 2.5 ml syrup, 2 times daily.

Children 2 – 5 years: 2.5 ml syrup three times daily.

Children over 5 years: 5 ml syrup two-three times daily.

For adults it is recommended 10 ml of Lambrotin 30 (ambroxol 30 mg /5 ml) 2–3 times a day.

In the treatment for longer than 7–14 days, the dose is reduced twice.

It is not recommended to use more than 4–5 days.

Drink plenty of fluids during the treatment (juice, tea, water).